Raben David
- SEC CIK
- 0002034679
In the past year, 5 open-market sale filings worth $1.15M and no purchases.
Current role at each company
- BCAX Bicara Therapeutics Inc.Chief Medical Officeras of Apr 28, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.15M
- 5 filings
- Net
- −$1.15M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Raben David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 (view filing) | Apr 27 | 1 day | Raben DavidChief Medical Officer | SSale | −5.50K | $22.88 | −$125.8K | −9.0%55.3K after | 10b5-1 |
| Mar 26, 2026 (view filing) | Mar 25 | 1 day | Raben DavidChief Medical Officer | SSale | −5.50K | $18.95 | −$104.2K | −9.0%55.3K after | 10b5-1 |
| Mar 5, 2026 (view filing) | Mar 3-4 | 2 days | Raben DavidChief Medical Officer | SSale | −16.5K | $18.52 | −$305.6K | −23.0%55.3K after | 2 lots10b5-1 |
| Nov 25, 2025 (view filing) | Nov 24-25 | 1 day | Raben DavidChief Medical Officer | SSale | −11.0K | $18.65 | −$205.1K | −23.7%35.5K after | 3 lots10b5-1 |
| Oct 10, 2025 (view filing) | Oct 9 | 1 day | Raben DavidChief Medical Officer | SSale | −22.0K | $18.45 | −$405.9K | −38.3%35.5K after | 10b5-1 |